candidate substance optimization
Scope
Date
~
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma introduces candidates for treating blood coagulation disease
South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Artificial intelligence
Hyundai Department Store uses AI to write advertising copy
South Korea's Hyundai Department Store Co. on Sunday said it will officially introduce on Thursday an artificial intelligence (AI) copywriting syste...
Feb 27, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korean IT firms rush for tie-ups to compete with ChatGPT
South Korean tech companies are rushing to form partnerships in different sectors to develop superior AI services to compete with ChatGPT, a chatbot...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Shareholder activism
Activist fund nominates director candidates for KT&G
A Singapore-based activist fund has stepped up pressure on the world’s fifth-largest tobacco maker KT&G Corp. to reform governance and boo...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom, Nokia demonstrate Korea's first open RAN base station
SK Telecom Co. said on Tuesday that it verified jointly with Nokia the stable 5G speed and coverage performance in a field test by installing a clou...
Jan 11, 2023 (Gmt+09:00)
-
Energy
POSCO to enter palm oil refining market in Indonesia
POSCO International Co., a trading arm of South Korea’s steel giant POSCO Co., will build a palm oil refining plant in Indonesia to foray into...
Jan 10, 2023 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical conducts product risk assessment first time in Korea
Lotte Chemical Corp. said on Tuesday that it is conducting a risk assessment for its products for the first time in the domestic chemical industry...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Leadership & Management
KT taps current CEO Ku as sole candidate for next chief
South Korea’s telecom giant KT Corp. has named current chief executive Ku Hyeon-mo the sole candidate for its next CEO during a board meeting ...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Advertising & Marketing
Korean LG CNS to expand digital marketing biz with DX tech
South Korea’s LG CNS Co., the information technology service arm of LG Group, is geared up to expand the digital marketing business for growth...
Dec 20, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Logistics
Doosan Logistics clinches deal to build Daiso's new hub center
South Korean system integrator Doosan Logistics Solution (DLS) has won a deal to build a new distribution center at 75 billion won ( $57 million)....
Dec 08, 2022 (Gmt+09:00)
-
Pension funds
NPS shortlists 6 candidates for chief investment officer opening
National Pension Service (NPS) of South Korea, the world’s third-largest pension fund managing 896.6 trillion won ($690.5 billion) as of end-S...
Dec 01, 2022 (Gmt+09:00)
-
Business & Politics
Tesla’s Musk names Korea among top candidate sites for Gigafactory
Tesla Inc. Chief Executive Elon Musk said on Wednesday that South Korea is among its top candidates to build in Asia another Gigafactory, the US ele...
Nov 23, 2022 (Gmt+09:00)
-
Pension funds
NPS narrows search for new CIO to two major candidates
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund managing 917.2 trillion won ($692 billion) in asset...
Nov 16, 2022 (Gmt+09:00)
-
Future mobility
What is a smart city? Hyundai Motor Group has a few ideas
Hyundai Motor Group on Monday released the results of its research project for smart cities in an online exhibition.In collaboration with the firm H...
Nov 01, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Lotte Card draws bid from Hana as key candidates back off
South Korea's Lotte Card Co. has drawn preliminary bids from Hana Financial Group, a leading banking group in the country, and two to three unidenti...
Sep 07, 2022 (Gmt+09:00)
-
Energy
Doosan Enerbility, Siemens' affiliate sign MOU for wind power business
Doosan Enerbility Co. announced Sunday it has signed an initial memorandum of understanding (MOU) with Siemens Gamesa Renewable Energy S.A. (SGRE) i...
Jun 27, 2022 (Gmt+09:00)
-
Leadership & Management
Hyundai Mobis CEO runs for ISO president as first Korean candidate
Hyundai Mobis Co. CEO Cho Sung-hwan has registered as a candidate for the next presidential election of the International Organization for Standar...
Jun 21, 2022 (Gmt+09:00)
-
Automobiles
Hankook Tire builds Asia’s largest proving ground for future car tires
Hankook Tire & Technology Co., South Korea’s top tire maker, said on Wednesday it has opened Asia’s largest proving ground to test t...
May 25, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand